These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 32138718)

  • 1. Comparison of survival outcomes between radio-chemotherapy and radical hysterectomy with postoperative standard therapy in patients with stage IB1 to IIA2 cervical cancer: long-term oncological outcome analysis in 37 Chinese hospitals.
    Liu P; Lin L; Kong Y; Huo Z; Zhu L; Bin X; Lang J; Chen C
    BMC Cancer; 2020 Mar; 20(1):189. PubMed ID: 32138718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of survival outcomes between laparoscopic surgery and abdominal surgery for radical hysterectomy as primary treatment in patients with stage IB2/IIA2 cervical cancer.
    Chen C; Guo J; Liu P; Li Z; Jiang H; Zhu Q; Bin X; Lang J
    J Obstet Gynaecol Res; 2021 Apr; 47(4):1516-1526. PubMed ID: 33527615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of survival outcomes of abdominal radical hysterectomy and radiochemotherapy IIA2 (FIGO2018) cervical cancer: a retrospective study from a large database of 63,926 cases of cervical cancer in China.
    He J; Li D; Shen P; Liang W; Kang S; Zhang Y; Zhao H; Liu M; Wang X; Lin Z; Bin X; Lang J; Liu P; Chen C
    Int J Clin Oncol; 2022 Mar; 27(3):619-625. PubMed ID: 34837596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between robot-assisted radical hysterectomy and abdominal radical hysterectomy for cervical cancer: A multicentre retrospective study.
    Chen B; Ji M; Li P; Liu P; Zou W; Zhao Z; Qu B; Li Z; Bin X; Lang J; Wang H; Chen C
    Gynecol Oncol; 2020 May; 157(2):429-436. PubMed ID: 32067814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
    Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage IB1-IIA2 cervical cancer.
    Kim SI; Cho JH; Seol A; Kim YI; Lee M; Kim HS; Chung HH; Kim JW; Park NH; Song YS
    Gynecol Oncol; 2019 Apr; 153(1):3-12. PubMed ID: 30642625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy.
    Hsieh HY; Huang JW; Lu CH; Lin JC; Wang L
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):99-108. PubMed ID: 29429800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study.
    Li L; Song X; Liu R; Li N; Zhang Y; Cheng Y; Chao H; Wang L
    BMC Cancer; 2016 Jul; 16():403. PubMed ID: 27387204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy.
    Takekuma M; Kasamatsu Y; Kado N; Kuji S; Tanaka A; Takahashi N; Abe M; Hirashima Y
    Int J Clin Oncol; 2016 Aug; 21(4):741-747. PubMed ID: 26857458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
    Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
    Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between laparoscopic and abdominal radical hysterectomy for stage IB1 and tumor size <2 cm cervical cancer with visible or invisible tumors: a multicentre retrospective study.
    Li P; Chen L; Ni Y; Liu J; Li D; Guo J; Liu Z; Jin S; Xu Y; Li Z; Wang L; Bin X; Lang J; Liu P; Chen C
    J Gynecol Oncol; 2021 Mar; 32(2):e17. PubMed ID: 33470062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2).
    Akhavan S; Alibakhshi A; Parsapoor M; Alipour A; Rezayof E
    BMC Cancer; 2021 Jun; 21(1):667. PubMed ID: 34088300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term oncological outcomes of laparoscopic versus abdominal surgery in stage Ⅰa1 （LVSI
    Chen CL; Kang S; Chen BL; Yang Y; Guo JX; Hao M; Wang WL; Ji M; Sun LX; Wang L; Liang WT; Wang SG; Li WL; Fan HJ; Liu P; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2020 Sep; 55(9):589-599. PubMed ID: 32957747
    [No Abstract]   [Full Text] [Related]  

  • 14. Hazard Ratio Analysis of Laparoscopic Radical Hysterectomy for IA1 With LVSI-IIA2 Cervical Cancer: Identifying the Possible Contraindications of Laparoscopic Surgery for Cervical Cancer.
    Li P; Liu P; Yang Y; Wang L; Liu J; Bin X; Lang J; Chen C
    Front Oncol; 2020; 10():1002. PubMed ID: 32733796
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of survival outcomes of neoadjuvant therapy and direct surgery in IB2/IIA2 cervical adenocarcinoma: a retrospective study.
    Ouyang P; Cai J; Gui L; Liu S; Wu NY; Wang J
    Arch Gynecol Obstet; 2020 May; 301(5):1247-1255. PubMed ID: 32221709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment results of adjuvant pelvic radiotherapy after radical hysterectomy for low-risk Stage IB1-IIA cervical cancer.
    Zhao D; Qiu H; Zhang H; Hong L; Zhang G; Xie C
    Jpn J Clin Oncol; 2017 Nov; 47(11):1024-1030. PubMed ID: 28973662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
    Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
    Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system.
    Osaku D; Komatsu H; Okawa M; Iida Y; Sato S; Oishi T; Harada T
    Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1054-1058. PubMed ID: 34794737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term outcomes of clinical responders to neoadjuvant chemotherapy followed by radical surgery in locally advanced cervical cancer.
    Li W; Liu P; He F; Sun L; Zhao H; Wang L; Guo J; Yang Y; Bin X; Lang J; Chen C
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4867-4876. PubMed ID: 36269389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dense neoadjuvant chemotherapy before radical surgery in cervical cancer: a retrospective cohort study and systematic literature review.
    Caruso G; Bruni S; Lapresa M; De Vitis LA; Parma G; Minicucci V; Betella I; Schivardi G; Peccatori F; Lazzari R; Cliby W; Aletti GD; Zanagnolo V; Maggioni A; Colombo N; Multinu F
    Int J Gynecol Cancer; 2024 Jan; 34(1):47-57. PubMed ID: 37949488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.